chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a healthcare professional and described the occurrence of bilateral conjunctivitis in a subject of unspecified age and gender who was vaccinated with Influenza vaccine (GlaxoSmithKline). On an unspecified date, the subject received a dose of Influenza vaccine (unknown). At an unspecified time after vaccination with Influenza vaccine, the subject experienced bilateral conjunctivitis and swollen eyes. The healthcare professional reported that a subject received a flu shot and experienced swollen eyes and bilateral conjunctivitis, no details were provided. At the time of reporting the outcome of the events were unspecified.
Partial immobility of arm. Pain when moving my arm also pain if I?m sitting in a certain position
dose drawn up on 12.27.22 @ 2:30pm but given on 12.28.22 @ 5:39pm, outside the 12 hr expiration and 24 hr pfizer stability data, will need to be repeated.
devel weakness & h/a w/in 2-3 hrs of receiving MMR vax; on 4MAy93 wouldn't wake up; mom needed to tap pt on face & gently shake; c/o breathing problem, hard to breathe, occasional cough; no temp balance not nl, staggered like a drunk;  n/v
Patient received an expired vaccine. This vaccine expired on 4/25/2021 at 1:25pm and was given on 4/26/2021. No adverse reaction has been reported
exactly 7 days after my vaccine, I developed a large area of cellulitis below the injection site
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concomitant medications and medical history reported. On 11-AUG-2015, the patient was inadvertently vaccinated with expired PNEUMOVAX23, (expire date 05-AUG-2015) (dose, route, lot not reported). This was supported. No adverse effects reported. Additional information has been requested.
scratchy throat; tired; headache; This is a spontaneous report from a contactable nurse (patient).  A 58-year-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), intramuscular in 24Dec2020 11:30 at a single dose in the left arm as Covid vaccine. The patient had no medical history. The patient no known allergies. Concomitant medication included propranolol (within the two weeks). The patient had no prior COVID vaccination and was not tested for COVID post vaccination. On an unknown date, the patient experienced scratchy throat, tired, and headache. No treatments received in response to the events reported. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). The outcome of the events scratchy throat, tired, and headache was recovered with lasting effects.   Information on the lot/batch number has been requested.
got the shot and got the shingles / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 6 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The patient reported case for herself. The age at vaccination was not reported. The patient got the shot and 6 months later got the shingles. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required. This case has been linked with US2021AMR177122 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR177122:same reporter
This case was reported by a pharmacist via call center representative and described the occurrence of pustule in a 81-year-old male patient who received SHINGRIX. Concurrent medical conditions included blood pressure high, blood cholesterol increased and diabetes. On 11th April 2018, the patient received the 1st dose of SHINGRIX .5 ml. On 2nd May 2018, 21 days after receiving SHINGRIX, the patient experienced pustule. On an unknown date, the outcome of the pustule was recovered/resolved. It was unknown if the reporter considered the pustule to be related to SHINGRIX. Additional details were provided as follows: This case was reported to the pharmacist by the patient's daughter. The reporter was not sure if the patient took his medications on the day of the vaccine but he took medications for high blood pressure, diabetes and high cholesterol. After receiving SHINGRIX, the patient had little pustular sores on the right side of his waist and nothing on the left side. Exact onset date was unknown, it might had been a day before reporting or on the day of reporting.
Basal cell carcinoma in nose; Alopecia Areata; Telugen effluvium; Lost lots of hair, eventually noticed it started to fall in patches.; This is a spontaneous report received from a contactable consumer.  A 39-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, in Arm Left on 31Mar2021 14:30 (Batch/Lot Number: Ep 1533) (at the age of 39 years-old) as single dose for covid-19 immunisation . The patient had received the first dose of vaccine on 31Mar2021 at 02:30 PM (Lot Ep 1533) in Left arm. The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient was not pregnant. Drug history included drug allergy to bactrim. On 05Apr2021 the patient experienced lost lots of hair, eventually noticed it started to fall in patches. She saw 2 doctors and both diagnosed alopecia areata and Telogen effluvium in May2021. At the same time while going through the process she was also diagnosed with a basal cell carcinoma in her nose. The adverse events resulted in the Doctor or other healthcare professional office/clinic visit . Treatment received for the adverse events inclued steroid shots, steroid topical creams, uv light tr. The outcome of the events was recovering.
Information has been received from licensed practical nurse concerning a 32 year old female with exercise induced asthma and no allergies who on 14-AUG-2007 was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 (Lot #0959F/655290) intramuscularly. Concomitant therapy included FLONASE and ALLEGRA. On 15-AUG-2007 the patient developed a fever, headache, arm swelling and experienced tunnel vision and vertigo. The patient was evaluated in the emergency room and was treated with MOTRIN, BENADRYL, and prednisone. No other information is available at this time. Additional information has been requested.
Anaphylactic reaction with EpiPen administration in vaccination clinic, followed by Rapid Response Team initiation and  immediate transport to Emergency Room.
Patient became dizzy, pale about 10 minutes following Moderna #1 vaccine. BP 85/47, P 53, patient laid flat with feet on chair. Five minutes later, second BP 128/78, patient's color resumed normal, reports no dizziness; Ten minutes later, third BP 123/72. Patient was drinking water and eating peanut butter crackers with mother, able to ambulate on own after waiting approximately 30 minutes from vaccination time.
maybe has covid/she and her son experienced the same kind of symptoms; maybe has covid/she and her son experienced the same kind of symptoms; Bad night sweats; tremors; low grade fever; headache; Fatigue; was hot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "maybe has covid/she and her son experienced the same kind of symptoms"; NIGHT SWEATS (non-serious), outcome "unknown", described as "Bad night sweats"; TREMOR (non-serious), outcome "unknown", described as "tremors"; PYREXIA (non-serious), outcome "unknown", described as "low grade fever"; HEADACHE (non-serious), outcome "unknown", described as "headache"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue"; FEELING HOT (non-serious), outcome "unknown", described as "was hot".  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101619284 same reporter /product, different patient, similar events
Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date; Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2022 at 12:25 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 07-Mar-2022 at 12:25 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on vaccine administration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Vaccine went into 2 to 8 degree Celsius in thaw state on or about 24 Dec 2021.  On 07 Mar 2022, the patient received booster dose.  Treatment information was not provided.   This case was linked to MOD-2022-542869 (Patient Link).
08/01/2021: Presented to ED via EMS due to altered mental status, fever, and lethargy x 2 days prior to admission. Patient tests positive for COVID, UTI with hematuria, with 89% 02 sat on room air.  08/02/2021: Patient mental status improvement.  08/03/2021: Patient had 94% O2 sat on room air after oxygen removal and was discharged.
Severe muscle aches arms, legs, and neck. Numbness in feet and R arm. Headaches and low grade fever. Overall weakness. 10/10-11/13. Elevated resp. problems on 11/12. Chest pain and pressure.
Patient has hives at the site of the injections and on his upper bodya nd back. Had injections at 8am  on 3-16-07 and was reported to the clinic at 4pm the same day.
Began with nausea, then itching began, had broken out in hives.  Lower lip and under the tongue swelled, also corner of mouth swelled.  Diarrhea and severe headache.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Tachycardia-Mild, Additional Details: Symptoms felt 3 hrs after administration. Went to Emergency Room however on the same day patient is stable
After Dose 4, I went on a trip. Sometime in August and September 2022 I was experiencing random chest pain and constant weakness. The weakness really troubled me although I?m 80 I?m very active, this is not normal for me. I contacted my doctor, and I was referred to a cardiologist. He ran a stress test, echocardiogram. The results showed there was some small weakness on one side of my heart. Because it wasn?t major, they sent me to a pulmonologist. The found three small nodules on my lungs. I had a reaction to a treatment that opened my air way. I was put on a medication to open my airways. I was just recently added a rescue inhaler. In meanwhile the pressure in my chest it has stopped after a month of using the inhaler, causing more congestion.
HIGH BLOOD PRESSURE; DISSOCIATION; FEEL LIKE ROOFIED; CAN'T FOCUS ON CONVERSATION; DIZZINESS; BURNING SENSATION IN BRAIN; CHILLS; FEVER; HEADACHE; BODY ACHES; This spontaneous report received from a patient concerned a 29 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1808982, expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced fever. On 09-APR-2021, the subject experienced headache. On 28-APR-2021, the subject experienced burning sensation in brain. On an unspecified date, the subject experienced high blood pressure, dissociation, feel like roofied, can't focus on conversation, and dizziness. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) increased to 190/100. The action taken with covid-19 vaccine was not applicable. The patient recovered from high blood pressure, and body aches, chills, fever, and headache on APR-2021, and the outcome of burning sensation in brain, dizziness, dissociation, feel like roofied and can't focus on conversation was not reported. This report was non-serious.
30 mins after injection-tingling upper back, severe headache, profusely sweating. Symptoms lasted about 6 hours
rash/seems to be having like rash reaction; It is Noticeable; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 16 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 29Nov2021 (Lot number: FJ1611) at the age of 16 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: RASH (non-serious) with onset 01Dec2021, outcome "not recovered", described as "rash/seems to be having like rash reaction; It is Noticeable". Therapeutic measures were not taken as a result of rash.  Additional information: Reporter had a question, reporter's daughter seems to be having like rash reaction to the Pfizer COVID shot. Was there anyway we can take her to get a medication or do we go back to '(Withheld)' or what we do. Prior vaccination (4 Weeks): Reporter stated: No. Reporter stated, "Sorry, the reporter was not quite sure what was it going to be but the reporter meant it was not too concerning but it was noticeable as we are just trying to get her checked. Reporter seriousness for My daughter seems to be having like rash reaction; It is Noticeable: Unspecified  Follow-up attempts are completed. No further information is expected.
5/10 began w/ swelling, pain and redness over (L) deltoid inoculation site. One episode of tactile fever that resolved. Urticaria developed on left leg and arm lasting one night. Resolved w/o meds. Continues to have dermal edema on (L) deltoid.
Information has been received from a consumer concerning a 20 year old female with no drug allergies and no medical history, who on 27-JUN-2007 was vaccinated with a 0.5mL third dose of Gardasil. There was no concomitant medication. On 18-JUL-2007 the patient had a PAP test that was positive for HPV. In November 2006 and January 2007 the patient was vaccinated with a first and second dose of Gardasil, respectively. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. No product quality complaint was involved. Additional information is not expected.
post nasal drainage, cough, hoarse voice, nausea,, slight headache, hot and clammy, shortness of breath, legs ache. starting 1/8/2022
Same evening of vaccine injection 3/24 - chills and severe headache and extreme fatigue.   Overnight - nausea, vomiting and fever 102.6.  Next morning 3/25, woke up and tried to get out of bed.  Legs were so weak they gave out and I fell out of bed on the floor.   I had no strength to get back up to get on the bed.  My wife could not lift me, so she called 911 for a "lift assist".  Paramedics were told I received the 2nd dose of the Covid vaccine the day before, so they picked me up off of the floor and put me back in bed.  They took my vitals - blood pressure was 116/73 and temperature was still 102.6.  Paramedics offered to take me to the hospital but I refused.  Paramedics told my wife that if my breathing became labored, she should get me to the ER or call 911 again.    I was not able to get out of bed the whole day on Thursday 3/25, because I was so weak I could not stand up, and I also had body aches and had to use a urinal because I could not walk to the bathroom.  My wife gave me Tylenol and the fever finally broke late evening of Thursday 3/25 and I started to feel a little bit better.  I had not eaten all day, but my wife made sure I stayed hydrated with water.  On Friday morning 3/26 I was able to sit up on the side of the bed, and I was able to walk with the assistance of a cane to the bathroom.  Extreme fatigue affected me all day Friday, but I did feel better.  Fever did not come back after it broke.  Saturday 3/27 - still experiencing extreme fatigue, but feel better overall.
Extreme hot, sweating, rash and itching all over chest, neck, back,  red and horrible itch on face and head, out of breath, fast heartbeat, dizzy
5APR pt was blotchy head to toe;6APR to PMD zyrtec given;7APR still redness top of head;diaper area, back of legs;child had no fever did not appear ill;
The team member reported her heart was racing, she became dizzy, nauseated, flushed, and felt like she was going to pass out.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 13-JUN-2016 the patient was vaccinated with an improperly stored dose of GARDASIL (lot # L040460, expiration date 27-MAY-2017, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 256 hours with the lowest recorded temperature of 1 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
probably polycellulitis; The whole half of the arm was really red and swollen; The whole half of the arm was really red and swollen; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), intramuscular on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced polycellulitis, the whole half of the arm was really red and swollen on an unspecified date. The reporter mentioned that a patient developed something that the reporter thought was probably polycellulitis after shot of unknown pneumonia vaccine product; product might have been Prevnar 13 but reporter was not sure. The patient called the doctor who sent them to a clinic to be seen that day and think theirs was maybe 3 days since they had gotten the unknown pneumonia vaccine if the reporter remembered correctly. This occurred maybe 6 months ago. The reporter just remembered the whole half of the arm was really red and swollen. The outcome of the events was unknown. Lot/batch number has been requested.; Sender's Comments: A contributory role of PREVNAR 13 cannot be fully excluded in triggering the onset of probably polycellulitis with the whole half of the arm was really red and swollen.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Pt received an expired dose of Hep B. Parents were advised to revaccinate patient. No adverse reactions have been reported.
A nurse reported that a 17 month old male received his 1st dose of Prevnar along with doses of Hib-Titer, MMR, Varivax and Tripedia on 3/1/01. The child's mother indicated that the Prevnar injection site was red and "more pronounced" compared to the other injections that the child had received. Additional information received from the reporter on 5/30/01, indicated that the child also received Hep-B vaccine on 3/1/01. The child recovered.
Pt recvd vax & exp nausea & vomiting; No further details are available; This case is considered to be invalid;
I should have gotten my period around the 5th of May and I did not; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 15:45 (Lot number: Er8736) at the age of 43 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: MENSTRUATION DELAYED (non-serious) with onset 2021, outcome "unknown", described as "I should have gotten my period around the 5th of May and I did not".  Additional Information: Facility where the most recent COVID-19 vaccine was administered was reported as Pharmacy or Drug Store. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There is no list of any other medications the patient received within 2 weeks of vaccination. The patient reported that, she received her first dose on 26Apr2021. She had no adverse reactions but she should have gotten her period around the 5th of May and she did not. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The device date was reported as 08Aug2021.  Follow-up attempts are completed. No further information is expected.
My joints began to ache, I developed a fever and chills and by 8:00pm, I was in so much pain I could hardly move (9-10 on the pain scale). I was completely nauseous and could not keep down any food.  The pain lessened the next day (7-8) but continued.  I'm now in day 3 -- and I still have pain at the 7-8 scale.  The fever has dropped, but I can't even smell food.